CLSI C52-A2

Toxicology and Drug Testing in the Clinical Laboratory; Approved Guideline, Second Edition, C52A2E

Clinical and Laboratory Standards Institute, 04/01/2007

Publisher: CLSI

File Format: PDF

$143.00$287.20

Description

Published:01/04/2007

Pages:68

This guideline addresses drug testing in the clinical laboratory, both for clinical and forensic purposes, and pertains to both drugs of abuse and other drugs normally encountered and analyzed by hospital laboratories.

The guideline discusses the preanalytical, analytical, and postanalytical considerations for specimen collection, methods of analysis, quality assurance, and the reporting and interpretation of results.

More CLSI standard pdf

CLSI EP09-A2-IR

Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline--Second Edition (Interim Revision), EP09A2IR

$90.00 $180.00

CLSI M100-S20-U

Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement, (June 2010 Update), M100S20U

$125.00 $251.66

CLSI M100-S20 Erratum

Erratum to Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement, M100S20

$109.00 $218.77

CLSI EP30-A (R2018)

Characterization and Qualification of Commutable Reference Materials for Laboratory Medicine; Approved Guideline, EP30AE

$90.00 $180.00